Sold by: Modus CreateÂ
Use AI/ML to accelerate biomarker discovery, molecular simulations, and target identification.
Overview
Traditional drug discovery processes are slow and resource-intensive, delaying breakthrough therapies. This 4-week POC uses AWS SageMaker & Bedrock to identify promising biomarkers, simulate molecule interactions, and optimize AI-driven drug discovery workflows. What’s Included: • AI-Powered Biomarker Discovery – Uses SageMaker to analyze genomics datasets for potential drug targets. • Molecular Simulation & Screening – Applies AI-driven modeling to predict compound interactions. • AWS-Powered Research Pipeline – Builds a scalable AI/ML workflow for preclinical drug development. •** Implementation Roadmap** – Plan for production deployment in AWS-powered R&D environments.
Highlights
- Accelerate Preclinical Drug Discovery – Reduces molecular screening time with AI simulations.
- Scalable AI/ML R&D Workflows – Enables predictive modeling for targeted therapy development.
- AWS SageMaker & Bedrock Integration – Optimized for life sciences research and AI-driven insights.
Details
Sold by
Delivery method
Deployed on AWS
New
Introducing multi-product solutions
You can now purchase comprehensive solutions tailored to use cases and industries.
Pricing
Custom pricing options
Pricing is based on your specific requirements and eligibility. To get a custom quote for your needs, request a private offer.
Legal
Content disclaimer
Vendors are responsible for their product descriptions and other product content. AWS does not warrant that vendors' product descriptions or other product content are accurate, complete, reliable, current, or error-free.